In a report released today, Andrew Semple from Echelon Wealth Partners reiterated a Buy rating on Indiva (NDVAF – Research Report), with a price target of C$0.50. The company's shares closed last Monday at $0.13, close to its 52-week low of $0.11. According to TipRanks.com, Semple is a 1-star analyst with an average return of -1.9% and a 22.1% success rate. Semple covers the Basic Materials sector, focusing on stocks such as Ascend Wellness Holdings LLC, Fire & Flower Holdings, and Green Thumb Industries. Currently, the analyst consensus on Indiva is a Moderate Buy with an average price target of $0.43.
https://www.tipranks.com/news/blurbs/echelon-wealth-partners-remains-a-buy-on-indiva-ndvaf?utm_source=advfn.com&utm_medium=referral
Indiva (QX) (USOTC:NDVAF)
Historical Stock Chart
From Jul 2022 to Aug 2022 Click Here for more Indiva (QX) Charts.
Indiva (QX) (USOTC:NDVAF)
Historical Stock Chart
From Aug 2021 to Aug 2022 Click Here for more Indiva (QX) Charts.